Literature DB >> 26650914

Early deterioration of residual hearing in patients with SLC26A4 mutations.

Bo Gyung Kim1, Kyung Jin Roh2, Ah Young Park2, Seung Chul Lee1, Bo Sung Kang3, Young Joon Seo4, Jong Dae Lee1, Jae Young Choi2.   

Abstract

OBJECTIVES/HYPOTHESIS: To compare changes in hearing in patients with SLC26A4 during early and late childhood. STUDY
DESIGN: Retrospective chart review.
METHODS: A total of 102 patients with biallelic SLC26A4 mutations visited the tertiary referral otolaryngology department between March 2005 and February 2015. Newborn hearing screening tests had been performed on 22 of these patients. We analyzed 26 patients who underwent hearing tests more than twice using the same method (auditory brainstem response/auditory steady state response/play audiometry) before and after 3 years of age. We analyzed changes in hearing levels according to age.
RESULTS: Among 22 patients with SLC26A4 mutations who underwent newborn hearing screening tests, seven (31.8%) passed the newborn hearing screening test in both ears, and six (27.3%) passed in one ear. Among 16 patients with SLC26A4 mutations who underwent hearing tests more than twice before age 3 years, the hearing levels of 14 (87.5%) deteriorated rapidly during this time. Among 16 patients with SLC26A4 mutations who underwent hearing tests more than twice after the age of 3 years, two (12.5%) patients' hearing levels deteriorated; the hearing levels of most of the patients were relatively stable.
CONCLUSIONS: These data suggest that many patients with SLC26A4 mutations have significant residual hearing at birth, and that the hearing deterioration in these patients occurs before 3 years of age. After age 3 years, the residual hearing was relatively stable and did not tend to deteriorate. Therefore, in patients with a pendrin mutation, early intervention to preserve residual hearing should be a clinical focus. LEVEL OF EVIDENCE: 4. Laryngoscope, 126:E286-E291, 2016.
© 2015 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  SLC26A4; hearing; mutation

Mesh:

Substances:

Year:  2015        PMID: 26650914     DOI: 10.1002/lary.25786

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  2 in total

Review 1.  Congenital hearing loss.

Authors:  Anna M H Korver; Richard J H Smith; Guy Van Camp; Mark R Schleiss; Maria A K Bitner-Glindzicz; Lawrence R Lustig; Shin-Ichi Usami; An N Boudewyns
Journal:  Nat Rev Dis Primers       Date:  2017-01-12       Impact factor: 52.329

2.  DNAJC14 Ameliorates Inner Ear Degeneration in the DFNB4 Mouse Model.

Authors:  Hye Ji Choi; Hyun Jae Lee; Jin Young Choi; Ik Hyun Jeon; Byunghwa Noh; Sushil Devkota; Han-Woong Lee; Seong Kug Eo; Jae Young Choi; Min Goo Lee; Jinsei Jung
Journal:  Mol Ther Methods Clin Dev       Date:  2019-11-30       Impact factor: 6.698

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.